Catalyst Wire Dossier Catalyst Wire Dossier

JTT-251

JTT-251 · Akros Pharma Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JTT-251, covering 2014-10-07 to 2014-10-07. Get the full timeline:

Most recent: Clinical Trial Update: Study of Safety, Tolerability and Pharmacokinetics of Single Oral JTT-251 Doses in Healthy and Type 2 Diabetic Subjects [Phase 1]

See pricing